# Transmuscular Quadratus Lumborum Block Plus Pericapsular Injection vs Pericapsular Injection

> **NCT04353414** · PHASE4 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 104 (actual)

## Conditions studied

- Hip Pain Chronic

## Interventions

- **PROCEDURE:** Transmuscular Quadratus Lumborum Block
- **PROCEDURE:** Pericapsular injection
- **DRUG:** Bupivacaine Hydrochloride

## Key facts

- **NCT ID:** NCT04353414
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-01
- **Primary completion:** 2022-02-17
- **Final completion:** 2022-02-23
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2022-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04353414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04353414, "Transmuscular Quadratus Lumborum Block Plus Pericapsular Injection vs Pericapsular Injection". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04353414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*